Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. Published in May 2024, the FLOW trial , for instance, looked at patients with diabetes and advanced kidney disease.

Hospital 66

Hospital Management Diabetes Patients 66

GeriPal

OCTOBER 17, 2024

He was describing his, like, 87 year old grandma who was placed on a low salt diabetic diet. So I have a two and a half year old, and during my last pregnancy, I had gestational diabetes. If they’re frail, if they’re falling, if they have cognitive impairment, they’re at higher risk of adverse drug events.

Primary Care 113

Primary Care Patient-Centered IT Patients 113

GeriPal

AUGUST 1, 2024

So if you already have a condition, you might be able to prevent events. But at any age, like, as Emily said, it is so important to pay attention to nutrition and healthy eating because it’s not just about, oh, chronic disease prevention or even treatment and management. And you can work at different levels of prevention.

IT 116

IT Diabetes Chronic Disease Patient-Centered 116